KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.91 $2.71 Thursday, 25th Apr 2024 CANF stock ended at $1.92. This is 1.03% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.62% from a day low at $1.92 to a day high of $1.97.
90 days $1.91 $2.71
52 weeks $1.71 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
Jul 12, 2022 $0.93 $0.94 $0.80 $0.88 406 622
Jul 11, 2022 $0.90 $1.03 $0.90 $1.01 882 006
Jul 08, 2022 $0.85 $0.90 $0.85 $0.90 134 257
Jul 07, 2022 $0.85 $0.87 $0.85 $0.85 71 696
Jul 06, 2022 $0.86 $0.88 $0.84 $0.84 178 512
Jul 05, 2022 $0.88 $0.90 $0.86 $0.89 182 204
Jul 01, 2022 $0.92 $0.93 $0.86 $0.90 195 030
Jun 30, 2022 $0.91 $0.93 $0.86 $0.92 938 205
Jun 29, 2022 $1.06 $1.12 $0.91 $1.02 15 918 685
Jun 28, 2022 $0.88 $0.91 $0.87 $0.88 99 335
Jun 27, 2022 $0.85 $0.91 $0.85 $0.91 76 369
Jun 24, 2022 $1.00 $1.00 $0.87 $0.87 790 159
Jun 23, 2022 $0.87 $0.90 $0.87 $0.89 67 621
Jun 22, 2022 $0.86 $0.92 $0.83 $0.87 73 330
Jun 21, 2022 $0.86 $0.91 $0.86 $0.87 55 439
Jun 17, 2022 $0.86 $0.87 $0.86 $0.86 21 436
Jun 16, 2022 $0.85 $0.87 $0.80 $0.85 75 358
Jun 15, 2022 $0.88 $0.90 $0.780 $0.85 126 701
Jun 14, 2022 $0.88 $0.90 $0.85 $0.88 231 407
Jun 13, 2022 $0.94 $0.95 $0.83 $0.89 108 426
Jun 10, 2022 $0.93 $0.96 $0.93 $0.93 87 494
Jun 09, 2022 $0.95 $1.00 $0.85 $0.97 156 354
Jun 08, 2022 $0.96 $0.99 $0.95 $0.98 41 312
Jun 07, 2022 $0.97 $0.98 $0.93 $0.97 38 001
Jun 06, 2022 $0.95 $0.99 $0.95 $0.97 30 603
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT